Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,912 | 5,372 | 2,330 | 4,008 | 3,683 |
| Receivables | 11,200 | 5,854 | 3,891 | 2,843 | 2,804 |
| Inventories | 2,842 | 3,240 | 2,195 | 2,622 | 1,805 |
| TOTAL | $26,867 | $21,096 | $10,921 | $11,892 | $9,522 |
| Non-Current Assets | |||||
| PPE Net | 25,604 | 28,652 | 26,419 | 26,942 | 26,960 |
| Investments And Advances | 4 | 97 | 189 | 292 | 400 |
| Intangibles | 1,878 | 485 | 546 | 607 | 8,208 |
| Other Non-Current Assets | 1,879 | 2,712 | 0 | 0 | 0 |
| TOTAL | $29,365 | $31,945 | $27,154 | $27,841 | $35,568 |
| Total Assets | $56,232 | $53,041 | $38,075 | $39,733 | $45,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,472 | 28,807 | 22,649 | 5,415 | 3,572 |
| Accounts payable and accrued liabilities | 2,710 | 3,625 | 7,131 | 3,412 | 2,760 |
| Accrued Expenses | 9,634 | 7,176 | 4,435 | 4,409 | 3,599 |
| TOTAL | $37,816 | $41,240 | $34,215 | $21,704 | $18,635 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,369 | 7,502 | 13,081 | 5,190 |
| Other Non-Current Liabilities | -182 | -324 | 419 | 486 | 57 |
| TOTAL | $340 | $1,738 | $7,869 | $13,446 | $5,190 |
| Total Liabilities | $38,156 | $42,978 | $42,083 | $35,149 | $23,825 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,209 | 72,172 | 61,737 | 49,815 | 49,615 |
| Common Shares | 76 | 70 | 50 | 50 | 50 |
| Retained earnings | -56,294 | -58,355 | -63,850 | -55,634 | -38,830 |
| Other shareholders' equity | 664 | 1,891 | 1,476 | 1,871 | 2,043 |
| TOTAL | $18,076 | $10,063 | $-4,009 | $4,584 | $21,265 |
| Total Liabilities And Equity | $56,232 | $53,041 | $38,075 | $39,733 | $45,090 |